Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Plx Pharma Inc (PLXP)

Plx Pharma Inc (PLXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,740
  • Shares Outstanding, K 9,156
  • Annual Sales, $ 570 K
  • Annual Income, $ -20,500 K
  • 60-Month Beta 4.63
  • Price/Sales 82.83
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PLXP with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.27
  • Number of Estimates 1
  • High Estimate -0.27
  • Low Estimate -0.27
  • Prior Year -0.45
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.00 +95.00%
on 11/02/20
6.42 -8.88%
on 11/23/20
+2.54 (+76.74%)
since 10/23/20
3-Month
3.00 +95.00%
on 11/02/20
6.42 -8.88%
on 11/23/20
+1.67 (+39.90%)
since 08/24/20
52-Week
1.80 +225.00%
on 03/25/20
6.42 -8.88%
on 11/23/20
+0.93 (+18.90%)
since 11/22/19

Most Recent Stories

More News
PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Update

--Announces $18 million private placement--

PLXP : 5.84 (+1.39%)
PLx Pharma Inc. Submits Supplemental New Drug Applications for VAZALORE(TM) 325 mg and 81 mg to U.S. Food and Drug Administration

-- FDA sets estimated completion review date for the end of February 2021 --

PLXP : 5.84 (+1.39%)
PLx Pharma, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 16, 2020 / PLx Pharma, Inc. (NASDAQ:PLXP) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 16, 2020 at 4:30...

PLXP : 5.84 (+1.39%)
PLx Pharma Inc. 2020 Third Quarter Financial Results and Business Update Conference Call Rescheduled to November 16, 2020

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on developing its clinically-validated and patent-protected PLxGuard(TM) delivery system to...

PLXP : 5.84 (+1.39%)
Canada Shines Light on Housing Figures Next Week

Monday U.S. Featured Earnings Air Lease Corporation (NYSE:AL) (Q3) EPS projected at ...

AL : 40.39 (+2.85%)
ELY : 19.50 (+0.67%)
VERI : 17.42 (+5.45%)
WES : 14.75 (+5.51%)
ZZZ.TO : 24.16 (+2.11%)
MOGO : 2.38 (-2.46%)
EGAN : 10.65 (-2.29%)
AAP : 150.25 (+3.22%)
BRKS : 69.79 (+1.81%)
BOS.TO : 17.12 (+1.97%)
HNL.TO : 5.72 (unch)
LNR.TO : 62.37 (+4.07%)
XAIR : 5.35 (-0.19%)
ENS : 83.77 (+3.32%)
CCMP : 154.59 (+3.03%)
PCOM : 11.75 (+3.34%)
GOOS.TO : 50.33 (+7.66%)
CHR.TO : 4.34 (+3.83%)
PRTH : 4.99 (+19.09%)
AXLA : 5.87 (+8.91%)
PDD : 144.06 (+2.13%)
VIVO : 16.87 (-4.09%)
PLXP : 5.84 (+1.39%)
EMA.TO : 55.13 (+0.18%)
AC.TO : 23.68 (+9.17%)
LUG.TO : 10.42 (-1.14%)
VII.TO : 5.46 (+3.80%)
PLx Pharma Inc. to Discuss 2020 Third Quarter Financial Results on November 13, 2020 Conference Call and Provide Business Update

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on developing its clinically-validated and patent-protected PLxGuard(TM) delivery system to...

PLXP : 5.84 (+1.39%)
PLx Pharma Inc. to Present Virtually at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on developing its clinically-validated and patent-protected PLxGuard(TM) delivery system to...

MHMNF : 54.5000 (unch)
PLXP : 5.84 (+1.39%)
Matinas BioPharma Appoints Industry Veteran Natasha Giordano to Board of Directors

Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced the appointment of Natasha Giordano to its Board of Directors as an independent director and a member of the audit committee, effective...

MTNB : 0.8203 (-4.62%)
PLXP : 5.84 (+1.39%)
PLx Pharma Inc. Reports Second Quarter 2020 Results and Provides Business Update

--Bioequivalence study of VAZALORE 325 mg on track with top-line data demonstrating bioequivalence to immediate release aspirin--

PLXP : 5.84 (+1.39%)
Housing Starts to be Posted in Canada Next Week

Monday U.S. Economic lookahead Job Openings (June) Featured Earnings Marriott International (NASDAQ:MAR) ...

MAR : 129.32 (+5.06%)
ON : 28.63 (+0.77%)
SEAS : 29.27 (+4.46%)
ABX.TO : 29.80 (-1.91%)
LNDC : 10.44 (+2.25%)
NEPT : 1.5500 (-1.90%)
SYY : 73.27 (+2.75%)
HBM.TO : 8.26 (+4.03%)
MEQ.TO : 71.00 (+0.18%)
OSK.TO : 3.36 (-1.75%)
WDO.TO : 10.00 (-0.79%)
YY : 88.67 (+0.19%)
LYFT : 39.92 (+1.45%)
PCOM : 11.75 (+3.34%)
FSZ.TO : 11.06 (+2.22%)
BIR.TO : 2.12 (+1.92%)
SIA.TO : 14.01 (+2.26%)
SPB.TO : 11.93 (+3.20%)
IQ : 22.18 (+0.18%)
MTBC : 10.59 (-4.51%)
WCC : 68.08 (+5.81%)
AQN.TO : 20.19 (+0.10%)
CCL-B.TO : 59.25 (+1.32%)
CAAS : 4.30 (-8.90%)
EFOI : 4.81 (-1.84%)
PLXP : 5.84 (+1.39%)
BTB-UN.TO : 3.74 (+0.81%)
HRX.TO : 14.41 (unch)
SII.TO : 38.40 (+0.10%)
BOS.TO : 17.12 (+1.97%)
MAR.TO : 0.52 (unch)
WEED.TO : 34.95 (+8.20%)
PLC.TO : 27.91 (-0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy and ranks in the Top 1% of all short term signal directions.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

PLx Pharma Inc. is a specialty pharmaceutical company. It focused on developing clinically validated and patent-protected PLxGuard(TM) delivery system to provide safe and effective aspirin products. PLx Pharma Inc., formerly known as Dipexium Pharmaceuticals Inc., is based in NEW YORK, United States....

See More

Key Turning Points

2nd Resistance Point 6.93
1st Resistance Point 6.35
Last Price 5.84
1st Support Level 5.25
2nd Support Level 4.73

See More

52-Week High 6.42
Last Price 5.84
Fibonacci 61.8% 4.66
Fibonacci 50% 4.11
Fibonacci 38.2% 3.56
52-Week Low 1.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar